Brief: Expres2ion's Associated Adaptvac Gets Payment After Bavarian's Phase Study

ExpreS2ion Biotech Holding AB

21/02/2024 10:19

Feb 21 (Reuters) - ExpreS2ion Biotech Holding AB
 EXPRS2.ST :
    * EXPRES2ION'S ASSOCIATED COMPANY ADAPTVAC RECEIVES
MILESTONE
PAYMENT FOLLOWING COMPLETION OF BAVARIAN NORDIC'S CLINICAL PHASE
III STUDY FOR THE COVID-19 VACCINE
    * ADAPTVAC APS ("ADAPTVAC") HAS RECEIVED 10 MILLION EUR AS A
RESULT OF BAVARIAN NORDIC HAVING COMPLETED CLINICAL PHASE III
STUDY OF COVID-19 VACCINE ABNCOV2

Source text for Eikon:  ID:nWkr9pZpmr 
Further company coverage:  EXPRS2.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))